AZD 9343

Drug Profile

AZD 9343

Latest Information Update: 07 Jul 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class Antiulcers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastro-oesophageal reflux

Most Recent Events

  • 08 Jun 2006 Discontinued - Phase-I for Gastro-oesophageal reflux in USA (unspecified route)
  • 22 Jul 2004 Phase-I clinical trials in Gastro-oesophageal reflux in USA (unspecified route)
  • 12 Feb 2003 Preclinical trials in Gastro-oesophageal reflux in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top